UroGen Pharma

UroGen Pharma is an American biopharmaceutical company that engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It was incorporated in 2004 and is based in Princeton, New Jersey.
UroGen Pharma stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

UroGen Pharma balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

UroGen Pharma cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

UroGen Pharma multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

UroGen Pharma profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
UroGen Pharma assets
UroGen Pharma cash flows

UroGen Pharma dividend policy

The company doesn't provide dividends

UroGen Pharma shares

TickerNameTypeNominal valueISINPrice
URGN:USUroGen PharmaCommon share-IL0011407140$15.76
UroGen Pharma news
10.05.2022
UroGen Pharma's GAAP loss for 3 months of 2022 was $28.392 million, up 9.5% from $25.935 million in the previous year. Revenue increased 81.2% to $13.564 million compared to $7.485 million a year earlier.
Source: {source} pictogram investors.urogen.com
Pictogram next
21.03.2022
UroGen Pharma's GAAP loss for 2021 was $110.82 million, down 13.7% from $128.484 million in the previous year. Revenue increased 4.07 times to $48.042 million from $11.799 million a year earlier.
Source: {source} pictogram investors.urogen.com
Pictogram next
All UroGen Pharma news
General information
Company nameUroGen Pharma
Tags#biotechnology, #cancer treatment
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address400 Alexander Park Princeton, NJ 08540 United States
Mailing address400 Alexander Park Princeton, NJ 08540 United States
Websiteinvestors.urogen.com